Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Good

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Insect Physiology|December 9, 2008
Contribution of gut bacteria to digestion and development of the velvetbean caterpillar, Anticarsia gemmatalisL E Visôtto, M G A Oliveira, R N C Guedes, et al.
Investigative Ophthalmology & Visual Science|May 14, 2010
Loss of tubedown expression as a contributing factor in the development of age-related retinopathyRobert L Gendron, Nora V Laver, William V Good, et al.
The Journal of Pediatrics|March 8, 2013
Dopamine-resistant hypotension and severe retinopathy of prematurityMelissa Catenacci, Shogo Miyagi, Andrea C Wickremasinghe, et al.
American Journal of Ophthalmology|January 15, 2024
Genetic Variants of the Beta-Adrenergic Receptor Pathways as Both Risk and Protective Factors for Retinopathy of PrematurityHélène Paradis, Salem Werdyani, Guangju Zhai, et al.
Ophthalmology|August 30, 2011
Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of ageBradley V Davitt, Graham E Quinn, David K Wallace, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|April 30, 2013
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of ageGraham E Quinn, Velma Dobson, Bradley V Davitt, et al.
Pharmacology & Therapeutics|February 20, 2018
The relaxin receptor as a therapeutic target - perspectives from evolution and drug targetingRoss A D Bathgate, Martina Kocan, Daniel J Scott, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2003
Risk analysis of prethreshold retinopathy of prematurityRobert J Hardy, Earl A Palmer, Velma Dobson, et al.
Ophthalmology|July 19, 2005
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurityBradley V Davitt, Velma Dobson, William V Good, et al.
BMC Infectious Diseases|November 21, 2018
Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from UgandaSergey Yegorov, Ronald M Galiwango, Sara V Good, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Insect Physiology|December 9, 2008
Contribution of gut bacteria to digestion and development of the velvetbean caterpillar, Anticarsia gemmatalisL E Visôtto, M G A Oliveira, R N C Guedes, et al.
Investigative Ophthalmology & Visual Science|May 14, 2010
Loss of tubedown expression as a contributing factor in the development of age-related retinopathyRobert L Gendron, Nora V Laver, William V Good, et al.
The Journal of Pediatrics|March 8, 2013
Dopamine-resistant hypotension and severe retinopathy of prematurityMelissa Catenacci, Shogo Miyagi, Andrea C Wickremasinghe, et al.
American Journal of Ophthalmology|January 15, 2024
Genetic Variants of the Beta-Adrenergic Receptor Pathways as Both Risk and Protective Factors for Retinopathy of PrematurityHélène Paradis, Salem Werdyani, Guangju Zhai, et al.
Ophthalmology|August 30, 2011
Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of ageBradley V Davitt, Graham E Quinn, David K Wallace, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|April 30, 2013
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of ageGraham E Quinn, Velma Dobson, Bradley V Davitt, et al.
Pharmacology & Therapeutics|February 20, 2018
The relaxin receptor as a therapeutic target - perspectives from evolution and drug targetingRoss A D Bathgate, Martina Kocan, Daniel J Scott, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2003
Risk analysis of prethreshold retinopathy of prematurityRobert J Hardy, Earl A Palmer, Velma Dobson, et al.
Ophthalmology|July 19, 2005
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurityBradley V Davitt, Velma Dobson, William V Good, et al.
BMC Infectious Diseases|November 21, 2018
Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from UgandaSergey Yegorov, Ronald M Galiwango, Sara V Good, et al.
Pageof 16